-
2
-
-
0000649367
-
The effect of chlorpromazine on glucose tolerance
-
Charatan FBE, Bartlett NG. 1955. The effect of chlorpromazine on glucose tolerance. J Mental Sci 191: 351-353.
-
(1955)
J. Mental Sci.
, vol.191
, pp. 351-353
-
-
Charatan, F.B.E.1
Bartlett, N.G.2
-
3
-
-
0025320188
-
A study on the types of diabetes mellitus in first degree relatives of diabetic patients
-
Cheta D, Dumitrescu C, Georgescu M, et al. 1990. A study on the types of diabetes mellitus in first degree relatives of diabetic patients. Diabetes Metab 16: 11-15.
-
(1990)
Diabetes Metab.
, vol.16
, pp. 11-15
-
-
Cheta, D.1
Dumitrescu, C.2
Georgescu, M.3
-
4
-
-
24444457035
-
Investigation of the metabolic effects of antipsychotics in patients with schizophrenia
-
(Poster). 51st Annual Meeting of the Canadian Psychiatric Association, Quebec. Canadian Psychiatric Association: Quebec
-
Chue P, Welch R. 2001. Investigation of the metabolic effects of antipsychotics in patients with schizophrenia. (Poster). 51st Annual Meeting of the Canadian Psychiatric Association, Quebec. Canadian Psychiatric Association: Quebec.
-
(2001)
-
-
Chue, P.1
Welch, R.2
-
5
-
-
0033947811
-
Diabetic ketoacidosis associated with risperidone treatment?
-
Croarkin PE, Jacobs KM, Bain KB. 2000. Diabetic ketoacidosis associated with risperidone treatment? Psychosomatics 41: 369-370.
-
(2000)
Psychosomatics
, vol.41
, pp. 369-370
-
-
Croarkin, P.E.1
Jacobs, K.M.2
Bain, K.B.3
-
6
-
-
0033756432
-
Prevalence and correlates of diabetes in national schizophrenia samples
-
Dixon L, Weiden P, Delahunty J, et al. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bull 26: 903-912.
-
(2000)
Schizophrenia Bull.
, vol.26
, pp. 903-912
-
-
Dixon, L.1
Weiden, P.2
Delahunty, J.3
-
7
-
-
0036913786
-
Glucose intolerance with atypical antipsychotics
-
Hedenmalm K, Hagg S, Stahl M, et al. 2002. Glucose intolerance with atypical antipsychotics. Drug Safety 25: 1107-1116.
-
(2002)
Drug Safety
, vol.25
, pp. 1107-1116
-
-
Hedenmalm, K.1
Hagg, S.2
Stahl, M.3
-
8
-
-
0001205689
-
Hyperglycaemia and glucosuria following chlorpromazine therapy
-
Hiles B. 1956. Hyperglycaemia and glucosuria following chlorpromazine therapy. J Am Med Assoc 162: 1651.
-
(1956)
J. Am. Med. Assoc.
, vol.162
, pp. 1651
-
-
Hiles, B.1
-
9
-
-
0347615169
-
Metabolic issues with atypical antipsychotics in primary care: Dispelling the myths
-
Kabinoff GS, Toalson P, Healey KM, et al. 2003. Metabolic issues with atypical antipsychotics in primary care: dispelling the myths. J Clin Psychiatry 5: 6-13.
-
(2003)
J. Clin. Psychiatry
, vol.5
, pp. 6-13
-
-
Kabinoff, G.S.1
Toalson, P.2
Healey, K.M.3
-
10
-
-
0000699617
-
The blood sugar curve in mental disease 11. The schizophrenia (dementia praecox) group
-
Kasanin J. 1926. The blood sugar curve in mental disease 11. The schizophrenia (dementia praecox) group. Arch Neurol Psychiatry 16: 414-419.
-
(1926)
Arch. Neurol. Psychiatry
, vol.16
, pp. 414-419
-
-
Kasanin, J.1
-
11
-
-
0035990397
-
Olanzapine associated diabetes mellitus
-
Koller EA, Doraiswamy PM. 2002. Olanzapine associated diabetes mellitus. Pharmacotherapy 22: 841-852.
-
(2002)
Pharmacotherapy
, vol.22
, pp. 841-852
-
-
Koller, E.A.1
Doraiswamy, P.M.2
-
12
-
-
0037014941
-
Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: Population based nested control study
-
Koro CE, Fedder DO, L'Italien GJ, et al. 2002. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested control study. Br Med J 332: 243-245.
-
(2002)
Br. Med. J.
, vol.332
, pp. 243-245
-
-
Koro, C.E.1
Fedder, D.O.2
L'Italien, G.J.3
-
13
-
-
0347615167
-
Prevalence of adult onset diabetes among outpatients receiving antipsychotic drugs
-
Lamberti J, Crilly J, Maharaj K, et al. 2003. Prevalence of adult onset diabetes among outpatients receiving antipsychotic drugs. Int Cong Schizophrenia Res 60: 360.
-
(2003)
Int. Cong. Schizophrenia Res.
, vol.60
, pp. 360
-
-
Lamberti, J.1
Crilly, J.2
Maharaj, K.3
-
14
-
-
0038220770
-
Patients on atypical antipsychotic drugs: Another high-risk group for type 2 diabetes
-
Lean MEJ, Pajonk F-G. 2003. Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetic Care 26: 1597-1605.
-
(2003)
Diabetic Care
, vol.26
, pp. 1597-1605
-
-
Lean, M.E.J.1
Pajonk, F.-G.2
-
15
-
-
0037315939
-
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical and atypical antipsychotics
-
Lindenmayer JP, Czabar P, Volavka P. 2003. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical and atypical antipsychotics. Am J Psychiatry 190: 290-296.
-
(2003)
Am. J. Psychiatry
, vol.190
, pp. 290-296
-
-
Lindenmayer, J.P.1
Czabar, P.2
Volavka, P.3
-
16
-
-
84905057245
-
Sugar tolerance in dementia praecox and other mental disorders
-
Lorenz WF. 1922. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry 8: 184-196.
-
(1922)
Arch. Neurol. Psychiatry
, vol.8
, pp. 184-196
-
-
Lorenz, W.F.1
-
18
-
-
0036252327
-
A retrospective comparison of weight, lipid and glucose changes between risperidone and olanzapine treated inpatients: Metabolic outcome after 1 year
-
Meyer JM. 2002. A retrospective comparison of weight, lipid and glucose changes between risperidone and olanzapine treated inpatients: metabolic outcome after 1 year. J Clin Psychiatry 63: 425-433.
-
(2002)
J. Clin. Psychiatry
, vol.63
, pp. 425-433
-
-
Meyer, J.M.1
-
19
-
-
0037223174
-
Prevalence of obesity, diabetes and obesity-related health risk factors, 2001
-
Mokdad AH, Ford ES, Bowman BA, et al. 2003. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289: 76-79.
-
(2003)
JAMA
, vol.289
, pp. 76-79
-
-
Mokdad, A.H.1
Ford, E.S.2
Bowman, B.A.3
-
21
-
-
0024565796
-
Family history of type 2 diabetes in schizophrenic patients
-
(letter)
-
Mukherjee S, Schnur DB, Reddy R. 1989. Family history of type 2 diabetes in schizophrenic patients (letter). Lancet i: 495.
-
(1989)
Lancet
, vol.1
, pp. 495
-
-
Mukherjee, S.1
Schnur, D.B.2
Reddy, R.3
-
22
-
-
0037317444
-
Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia
-
Ryan MC, Collins P, Thakore JH. 2003. Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. Am J Psychiatry 160: 284-289.
-
(2003)
Am. J. Psychiatry
, vol.160
, pp. 284-289
-
-
Ryan, M.C.1
Collins, P.2
Thakore, J.H.3
-
23
-
-
0043170918
-
Effect of acute psychotic stress in non-diabetic subjects on B cell function and insulin sensitivity
-
Shiloah E, Witz S, Abramovitch Y, et al. 2003. Effect of acute psychotic stress in non-diabetic subjects on B cell function and insulin sensitivity. Diabetes Care 26: 1462-1467.
-
(2003)
Diabetes Care
, vol.26
, pp. 1462-1467
-
-
Shiloah, E.1
Witz, S.2
Abramovitch, Y.3
-
24
-
-
24444458763
-
Risk factors for treatment emergent glucose abnormalities in patients with schizophrenia
-
Poster presentation, Collegium International Neuropsychopharmacologium, June 23-27. CINP: Montreal
-
Sowell MO, Mukhopadhyay N, Cavazzoni P. 2002. Risk factors for treatment emergent glucose abnormalities in patients with schizophrenia. Poster presentation, Collegium International Neuropsychopharmacologium, June 23-27. CINP: Montreal.
-
(2002)
-
-
Sowell, M.O.1
Mukhopadhyay, N.2
Cavazzoni, P.3
|